DARE: Several Important Milestones, Including Ovaprene PCT Read-Out, Anticipated Later This Year - Yahoo Finance

DARE: Several Important Milestones, Including Ovaprene PCT Read-Out, Anticipated Later This Year  Yahoo Finance

R&D expense, including license fees, was $1.8M, compared to $1.2M and $1.9M in the prior-year and three-month periods, respectively. We note that Q1 ...



Comments

Popular posts from this blog

Keto crotch: Is it real and how to treat it

Shave your pubic hair if you want, but not at these times